TABLE 2.
Study type | Cancer type | Research design | Outcomes | Ref |
---|---|---|---|---|
Retrospective | Gastric cancer | Propofol vs. Sevoflurane | Improved survival | Zheng et al. (2018) |
Retrospective | Gastric cancer | Propofol vs. Desflurane | Improved survival and reduced the risk of recurrence | Huang et al. (2020b) |
Retrospective | Hepatocellular carcinoma | Propofol vs. Inhalation anesthetics | Decreased 2-year recurrence | Koo et al. (2020) |
Retrospective | Hepatocellular carcinoma | Propofol vs. Desflurane | Better survival | Lai et al. (2019a) |
Retrospective | Hepatocellular carcinoma | Propofol vs. Sevoflurane | Reduced mortality and recurrence | Meng et al. (2020) |
Retrospective | Intrahepatic cholangiocarcinoma | Propofol vs. Desflurane | Improved survival and reduced the recurrence | Lai et al. (2019b) |
Retrospective | Colon cancer | Propofol vs. Desflurane | Better survival | Wu et al. (2018) |
Retrospective | Esophageal cancer | Propofol vs. Inhalation anesthetics | Better overall and recurrence-free survival | Jun et al. (2017) |
Retrospective | Pancreatic cancer | Propofol vs. Desflurane | Improved survival | Lai et al. (2020a) |
Prospective | Bladder cancer | Propofol vs. Sevoflurane | Improved disease-free Survival | Guerrero Orriach et al. (2020) |
Retrospective | Prostate cancer | Propofol vs. Desflurane | Improved overall survival | Lai et al. (2020b) |
Retrospective | Lung cancer | Propofol vs. Inhalation anesthetics | Better prognosis | Hayasaka et al. (2021) |
Retrospective | Glioblastoma | Propofol vs. Desflurane | Better survival | Huang et al. (2021) |
Retrospective | Breast cancer | Propofol vs. Sevoflurane | Better survival | Enlund et al. (2020) |
Retrospective | Breast cancer | Propofol vs. Sevoflurane | Reduced local regional recurrence | (Zhang et al., 2021b), (Zhang et al., 2022b) |
Retrospective | Breast cancer | Propofol vs. Desflurane | No difference | Huang et al. (2019) |
Retrospective | Breast cancer | Propofol vs. Inhalation anesthetics | No difference | Yoo et al. (2019) |
Retrospective | Breast cancer | Propofol vs. Sevoflurane | No difference | Shiono et al. (2020) |
Prospective | Breast cancer | Propofol vs. Sevoflurane | No difference | Yan et al. (2018) |
Retrospective | Gastric cancer | Propofol vs. Inhalation anesthetics | No difference | Oh et al. (2019) |
Retrospective | Digestive tract tumor | Propofol vs. Inhalation anesthetics | No difference | Makito et al. (2020) |
Retrospective | Glioblastoma | Propofol vs. Sevoflurane | No difference | Schmoch et al. (2021) |
Retrospective | Glioma | Propofol vs. Sevoflurane | No difference | Dong et al. (2020) |